tiprankstipranks
Entheon Biomedical (TSE:ENBI)
:ENBI
Canadian Market
Want to see TSE:ENBI full AI Analyst Report?

Entheon Biomedical (ENBI) Financial Statements

16 Followers

Entheon Biomedical Financial Overview

Entheon Biomedical's market cap is currently C$1.39M. The company's EPS TTM is C$; its P/E ratio is -3.72; Entheon Biomedical is scheduled to report earnings on April 24, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Feb 26Feb 25Feb 24Feb 23Feb 22
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 250.32KC$ 189.68KC$ 21.67K
Gross ProfitC$ 0.00C$ 0.00C$ 250.32KC$ 189.68KC$ 9.13K
Operating IncomeC$ -334.22KC$ -333.00KC$ -313.00KC$ -3.60MC$ -8.21M
EBITDAC$ -334.22KC$ -318.00KC$ 13.99KC$ -3.60MC$ -8.21M
Net IncomeC$ -324.01KC$ -318.00KC$ -300.00KC$ -8.52MC$ -8.89M
Balance Sheet
Cash & Short-Term InvestmentsC$ 321.83KC$ 136.49KC$ 344.63KC$ 680.17KC$ 2.05M
Total AssetsC$ 353.78KC$ 185.14KC$ 401.08KC$ 769.22KC$ 9.98M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -321.83KC$ -136.49KC$ -344.63KC$ -680.17KC$ -2.05M
Total LiabilitiesC$ 29.75KC$ 39.81KC$ 85.33KC$ 154.65KC$ 927.71K
Stockholders' EquityC$ 324.03KC$ 145.33KC$ 315.75KC$ 614.57KC$ 9.05M
Cash Flow
Free Cash FlowC$ -314.66KC$ -355.64KC$ -359.93KC$ -1.95MC$ -5.71M
Operating Cash FlowC$ -314.66KC$ -355.64KC$ -359.93KC$ -1.95MC$ -5.62M
Investing Cash FlowC$ 0.00C$ 0.00C$ 24.40KC$ 585.64KC$ -98.87K
Financing Cash FlowC$ 500.00KC$ 147.50KC$ 0.00C$ 0.00C$ 4.98M
Currency in CAD

Entheon Biomedical Earnings and Revenue History

Entheon Biomedical Debt to Assets

Entheon Biomedical Cash Flow

Entheon Biomedical Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.